Home
Conditions
Thoracic Neoplasms

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,031 public trials 1,839 recruiting studies

Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Recruiting

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

NCT05334277

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: The First Hospital of Jilin University Changchun, China

Sichuan Provincial People's Hospital Chengdu, China

Dongguan People's Hospital Dongguan, China

Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang People's hospital Dongyang, China

View all 26 locations

View Trial Details

Recruiting

A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

NCT04996121

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Trial Exploring Combined Neoadjuvant Therapy With Pembrolizumab/Lenvatinib + Adjuvant Pembrolizumab in Pat. With NSCLC

NCT04875585

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Medical University Innsbruck Innsbruck, Tyrol, Austria

View Trial Details

Recruiting

Neoadjuvant Furmonertinib Plus Bevacizumab or Furmonertinib Monotherapy for Resectable and Potentially Resectable Stage III-IVA EGFR Mutation-Positive Lung Adenocarcinoma

NCT05503667

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option

NCT04926584

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Klinikum Esslingen Esslingen am Neckar, Germany

View Trial Details

Recruiting

A Real World Study of Ensartinib in Advanced ALK-positive NSCLC

NCT05498064

Conditions: Anaplastic Lymphoma Kinase I1171N, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

China Lung Cancer Screening (CLUS) Study Version 3.0

NCT05494021

Conditions: Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations: Shanghai Chest hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

NCT05366478

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +30 more
Locations: Tianjin Beichen Hospital Tianjin, China

View Trial Details

Recruiting

Neoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy

NCT05469022

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Konkuk University Medical Center Seoul, South Korea

View Trial Details

Recruiting

Taiwan Cancer Moonshot Project

NCT05248763

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasms, +30 more
Locations: National Taiwan University Hospital Taipei, Taiwan

View Trial Details

Thoracic Neoplasms

Thoracic Neoplasms trial results

Related conditions